-
1
-
-
0032737294
-
End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions
-
Ritz E, Rychlik I, Locatelli F, et al. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. Am J Kidney Dis. 1999 ; 34: 795-808 (Pubitemid 29521694)
-
(1999)
American Journal of Kidney Diseases
, vol.34
, Issue.5
, pp. 795-808
-
-
Ritz, E.1
Rychlik, I.2
Locatelli, F.3
Halimi, S.4
-
2
-
-
0029076841
-
Effect of intensive therapy on the development and progression of diabetic nephropathy in the diabetes control and complications trial
-
Effect of intensive therapy on the development and progression of diabetic nephropathy in the diabetes control and complications trial. Kidney Int. 1995 ; 47: 1703-1720
-
(1995)
Kidney Int
, vol.47
, pp. 1703-1720
-
-
-
3
-
-
0034641568
-
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
-
Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. Br Med J. 2000 ; 321: 405-412 (Pubitemid 30609442)
-
(2000)
British Medical Journal
, vol.321
, Issue.7258
, pp. 405-412
-
-
Stratton, I.M.1
Adler, A.I.2
Neil, H.A.W.3
Matthews, D.R.4
Manley, S.E.5
Cull, C.A.6
Hadden, D.7
Turner, R.C.8
Holman, R.R.9
-
4
-
-
70349690296
-
Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria
-
Persson F, Rossing P, Reinhard H, et al. Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria. Diabetes Care. 2009 ; 32: 1873-1879
-
(2009)
Diabetes Care
, vol.32
, pp. 1873-1879
-
-
Persson, F.1
Rossing, P.2
Reinhard, H.3
-
5
-
-
38649102508
-
Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension
-
DOI 10.3317/jraas.2007.028
-
Uresin Y, Taylor AA, Kilo C, et al. Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension. J Renin Angiotensin Aldosterone Syst. 2007 ; 8: 190-198 (Pubitemid 351166266)
-
(2007)
JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
, vol.8
, Issue.4
, pp. 190-198
-
-
Uresin, Y.1
Taylor, A.A.2
Kilo, C.3
Tschope, D.4
Santonastaso, M.5
Ibram, G.6
Fang, H.7
Satlin, A.8
-
6
-
-
44849114597
-
Aliskiren combined with losartan in type 2 diabetes and nephropathy
-
DOI 10.1056/NEJMoa0708379
-
Parving H-H, Persson F, Lewis JB, et al. Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med. 2008 ; 358: 2433-2446 (Pubitemid 351793017)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.23
, pp. 2433-2446
-
-
Parving, H.-H.1
Persson, F.2
Lewis, J.B.3
Lewis, E.J.4
Hollenberg, N.K.5
-
7
-
-
59049099281
-
The importance of the intrarenal renin-angiotensin system
-
Velez JC. The importance of the intrarenal renin-angiotensin system. Nat Clin Pract Neph. 2009 ; 5: 89-100
-
(2009)
Nat Clin Pract Neph
, vol.5
, pp. 89-100
-
-
Velez, J.C.1
-
8
-
-
0023950461
-
Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications
-
Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988 ; 318: 1315-1321
-
(1988)
N Engl J Med
, vol.318
, pp. 1315-1321
-
-
Brownlee, M.1
Cerami, A.2
Vlassara, H.3
-
9
-
-
84856007395
-
For the Renin Angiotensin System Study (RASS) group. Benefits of renin-angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control
-
Harindhanavudhi T, Mauer M, Klein R, et al. for the Renin Angiotensin System Study (RASS) group. Benefits of renin-angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control. Diabetes Care. 2011 ; 34: 1838-1842
-
(2011)
Diabetes Care
, vol.34
, pp. 1838-1842
-
-
Harindhanavudhi, T.1
Mauer, M.2
Klein, R.3
-
10
-
-
79957775948
-
For the REIN Study Group. ACE inhibition is renoprotective among obese patients with proteinuria
-
Mallamaci F, Ruggenenti P, Perna A, et al. for the REIN Study Group. ACE inhibition is renoprotective among obese patients with proteinuria. J Am Soc Nephrol. 2011 ; 22: 1122-1128
-
(2011)
J Am Soc Nephrol
, vol.22
, pp. 1122-1128
-
-
Mallamaci, F.1
Ruggenenti, P.2
Perna, A.3
-
11
-
-
34548420712
-
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial
-
DOI 10.1016/S0140-6736(07)61303-8, PII S0140673607613038
-
Patel A. MacMahon S, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial. Lancet. 2007 ; 370: 829-840 (Pubitemid 47362321)
-
(2007)
Lancet
, vol.370
, Issue.9590
, pp. 829-840
-
-
Patel, A.1
-
12
-
-
65249182083
-
Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): Rationale and study design
-
Parving H-H, Brenner BM, McMurray JJ, et al. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): Rationale and study design. Nephrol Dial Transplant. 2009 ; 24: 1663-1671
-
(2009)
Nephrol Dial Transplant
, vol.24
, pp. 1663-1671
-
-
Parving, H.-H.1
Brenner, B.M.2
McMurray, J.J.3
|